Pelitinib

Pelitinib, also known as EKB569 and WAY-172569, is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity. EKB-569 irreversibly binds covalently to epidermal growth factor receptors (EGFR) ErbB-1, -2 and -4, thereby inhibiting receptor phosphorylation and signal transduction and resulting in apoptosis and suppression of proliferation in tumor cells that overexpress these receptors.
Supplier Alfa Cytology
Product # BC0419
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, inquire
Feedback